Healthcare (Prescription Drugs)

SB 20 would change how health insurers and pharmacy benefits managers handle prior authorization for prescription drugs in New Mexico. It prohibits requiring prior authorization for medications treating serious mental illnesses (such as schizophrenia, depression, or bipolar disorder), ensuring patients can access these drugs without delays. For drugs managing chronic conditions (like diabetes or high blood pressure), the bill limits prior authorization reviews to once every three years instead of more frequent checks. The law also requires the state insurance office to standardize the process, create a uniform form for requests, and monitor compliance to prevent unnecessary delays in care.